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Abstract
Magnetic Resonance Imaging (MRI) is of fundamental importance in neuroscience, providing good
contrast and resolution, as well as not being considered invasive. Despite the development of newer
techniques involving radiopharmaceuticals, it is still a recommended tool in Alzheimer’s Disease (AD)
neurological practice to assess neurodegeneration, and recent research suggests that it could reveal changes
in the brain even before the symptomatology appears. In this paper we propose a method that performs
a Spherical Brain Mapping, using different measures to project the three-dimensional MR brain images
onto two-dimensional maps revealing statistical characteristics of the tissue. The resulting maps could
be assessed visually, but also perform a significant feature reduction that will allow further supervised
or unsupervised processing, reducing the computational load while maintaining a large amount of the
original information. We have tested our methodology against a MRI database comprising 180 AD affected
patients and 180 normal controls, where some of the mappings have revealed as an optimum strategy for
the automatic processing and characterization of AD patterns, achieving up to a 90.9% of accuracy, as
well as significantly reducing the computational load. Additionally, our maps allow the visual analysis
and interpretation of the images, which can be of great help in the diagnosis of this and other types of
dementia.
I. Introduction
Alzheimer’s Disease (AD) is currently the most common neurodegenerative disease in the world,
with more than 44.4 million affected people, and it is likely to have increased up to 135.5 million
by 2050. According to research, most people currently living with this type of dementia have not
received a formal diagnosis [1]. In this task, the development of medical imaging has represented
a major breakthrough, allowing the physicians to explore a number of structural and functional
biomarkers that previously could only be accessed post-mortem.
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Recently, a number of very specific radiopharmaceuticals, such as Pittsburgh compound B
(PiB), a radioactive analog of thioflavin T that binds to fibrillar amyloid-beta (Aβ), have been
developed. However, their invasive nature and their technical requirements -specially when the
half-life of the radioactive element is usually low, and therefore, its synthesis requires a nearby
cyclotron- make them unusual in the clinical practice. Conversely, Magnetic Resonance Imaging
(MRI) is a more widespread technique that allows the characterization of brain atrophy, and
accordingly, is far more established in clinical practice.
Therefore, MR brain images have been extensively used in the diagnosis of AD by assessing
neurodegeneration on grey matter (GM) and White Matter (WM) tissues. Research has shown
in [2, 3, 4, 5] that neurodegeneration in Alzheimer’s Disease mainly occurs in the GM tissue.
Particularly grey matter loss has been described in the Hippocampus and Parahippocampal lobes,
according to the NINCDS-ADRDA criteria for AD diagnosis [5], with further atrophy described
in the medial temporal structures, the Posterior Cingulate gyrus and adjacent Precuneus [2].
Moreover, significantly lower volumes of certain regions in GM and WM have been considered a
promising biomarker and predictor of the progression of AD in a longitudinal study involving
Mild Cognitive Impairment (MCI) patients [3], and some structures in the striatum (putamen and
caudate nucleus) have shown important volume abnormalities [4]. All these data suggest that
many of the symptoms of AD can be observed in anatomical MR images even in early stages of
the disease, which could be of great help in its successful diagnosis and treatment.
Notwithstanding the utility of MRI, the task of examining the images currently depends on
several qualitative or semi-quantitative analyses, and relies often on the examiner’s subjectivity
[6]. Therefore, the development of objective, quantitative automatic methods is desirable. For
this purpose, a number of statistical tools and algorithms have been developed, leading to what
is known as the Computer Aided Diagnosis (CAD) paradigm. A large number of analysis rely
on univariate approaches, using SVM and Voxels As Features [6] or the processing of different
Regions of Interest (ROIs) [7, 8], along with the statement of specific anatomical biomarkers to
predict AD, like cortical thickness [9, 10]. Other multivariate approaches, which consider the
brain as a whole, have been proposed in the literature, either using component-based methods
[11, 12, 13, 14] or different classification approaches [15, 16, 17]. Most approaches to this task
imply the addition of a priori knowledge about the different areas in the brain, and its subsequent
study, obtaining high accuracy in the detection of the disease [7, 13].
The main aim of this work is to provide a new framework that allows the mapping of a 3D brain
image to a two-dimensional space by means of some statistical measures [18]. The system is based
on a conversion from 3D spherical to 2D rectangular coordinates. For each spherical coordinate
pair (θ, ϕ), a vector containing all voxels in the radius is selected, and a number of values are
computed, including statistical values (average, entropy, kurtosis) and morphological values (tissue
thickness, distance to the central point, number of non-zero blocks). These values conform a
two-dimensional image that can be computationally or even visually analysed. In this paper, we
proceed using an statistical mask computed using a two-sample t-Test, and a SVM classifier. We
have achieved performance results that match those obtained with a priori information but using
a complete automated procedure, which furthermore reduces the dimensionality of the original
images from more than two million voxels to hardly tens of thousands pixels. These maps can
be successfully used by itself, but also allow further processing by using them combined and
applying some univariate or multivariate algorithms for dimensional reduction.
Figure 1 gives an overview of the procedure used in this article. First, the MRI T1 brain images
are segmented, and mapped onto two dimensions using our proposed Statistical Brain Mapping
algorithm (see Sec. II.2). Then, the most relevant voxels, according to the t-values obtained by a
two-sample t-Test, are selected (Sec. II.5) and a feature vector is constructed with them. Finally,
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Figure 1: Flow diagram of the procedure used in the textural analysis of projected MR brain images.
we train and test a SVM classifier in a AD vs not AD (normal controls, NC) paradigm to assess
the ability of our 2D mappings in the detection of Alzheimer’s Disease.
II. Materials and Methods
II.1. MRI Brain Image database
Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was launched in 2003 as a
public-private partnership, led by Principal Investigator Michael W. Weiner, MD. The primary goal
of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission
tomography (PET), other biological markers, and clinical and neuropsychological assessment
can be combined to measure the progression of mild cognitive impairment (MCI) and early
Alzheimer’s disease (AD).
The database used in this article was extracted from the ADNI1: Screening 1.5T (subjects who
have a screening data) and contains 1075 T1-weighted MR images (for further information, see
www.adni-info.org).
In this work, a total number of 360 individuals (180 AD and 180 NC) have been randomly
selected to avoid class prevalence. The images were preprocessed, co-registered and segmented
using the Statistical Parametric Mapping (SPM) software [19], and the Voxel-Based-Morphometry
8 (VBM8) toolbox [20]. First, the preprocessing was performed using a nonlinear deformation field
using the tissue probability maps provided by the International Consortium for Brain Mapping
(ICBM). Secondly, we affine registered the data to the Montreal Neurological Institute (MNI) space
and resized to 121× 145× 121 voxel. Later, we performed the co-registration using the high-
dimensional Dartel normalization using the standard Dartel template provided by VBM8. Finally,
the images were segmented using VBM8 again, yielding probability maps that consist of values in
the range (0, 1) for each voxel. These values estimate each voxel’s membership probability (WM,
GM or Cerebro-Spinal Fluid), although CSF maps were not used in our experiments.
II.2. Spherical Brain Mapping
The technique proposed to perform the mapping of the 3D brain images to a 2D map using
spherical coordinates -from now on Spherical Brain Mapping (SBM)- is based on the use of
spherical coordinates in the brain. A base point is set in the central voxel of the MRI image, and a
mapping vector v`,’ of length N is defined for each inclination (θ) and azimuth (ϕ) angles in the
range 0◦ < θ < 180◦ and 0◦ < ϕ < 360◦ (see Figure 2). Therefore, we will define the sampled set
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Vθ,ϕ, a set that contains P voxels crossed by the sampling vector v`,’. For each set v`,’, a mapping
value v is computed from the sampled voxels Vθ,ϕ, depending on the measure used. In this section,
six basic measures are proposed:
Figure 2: Illustration of the computation of the mapping vector v`,’, the angles θ and ϕ and the r-neighbourhood of v
(see Section II.4).
• A basic brain surface approach, that accounts for the distance between the central voxel and
the last tissue voxel in Vθ,ϕ that is greater than a threshold Ith. This might allow our system
to observe structural degeneration and tissue loss in the surface of the tissue.
vsur f = arg max
i
{Vθ,ϕ(i) > Ith} ∀i = 1, . . . P (1)
• Another parameter used is thickness of the tissue. This can be useful when measuring the
thickness of segmented Gray Matter or White Matter MR images. It is defined as the distance
between the last and first elements in Vθ,ϕ with an intensity greater than a threshold Ith
(typically 0):
vthick = arg max
i
{Vθ,ϕ(i) > Ith} − arg min
i
{Vθ,ϕ(i) > Ith} ∀i = 1, . . . P (2)
• The number of folds represents the number of overlapping segments of tissue in the set Vθ,ϕ.
It is computed by thresholding Vθ,ϕ using the value Ith and counting the number of resulting
connected subsets. Let Aθ,ϕ be the set that contains all the indices of the voxels in Vθ,ϕ with
an intensity greater than Ith:
Aθ,ϕ = {i / Vθ,ϕ(i) > Ith} (3)
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where Aθ,ϕ ∈N. Let us divide Aθ,ϕ in J disjoint connected subsets so that:
Aθ,ϕ = A1θ,ϕ ∪ A2θ,ϕ ∪ · · · ∪ A
J




θ,ϕ = ∅ ∀i, j (4)
Therefore, our vn f = J, the number of disjoint connected subsets in Aθ,ϕ.





Vθ,ϕ(i) ∀i = 1, . . . P (5)
• The entropy assumes that the set Vθ,ϕ is a probability mass vector (probability of belonging
to a certain tissue, normalized) and computes v as:
vent = ∑
i
Vθ,ϕ(i) ∗ log(Vθ,ϕ(i)) ∀i ∈ argi{Vθ,ϕ(i) > 0} (6)
• The uncorrected kurtosis, also known as fourth standardized moment, of the set Vθ,ϕ in











)2)2 ∀i = 1, . . . P (7)
where V̄θ,ϕ is the average of all voxels in Vθ,ϕ (same value as vav, described in Eq. 5).
The resulting GM and WM maps are depicted in Figure 3.
The resulting maps will contain the value v mapped in each direction (θ, ϕ). As the inclination
angle θ ranges from 0◦ to 180◦ and the azimuth ϕ from 0◦ to 360◦, the resulting maps will have a
size of 181× 361, where each pixel is the v value for each direction. The whole algorithm can be
downloaded at http://wdb.ugr.es/~fjesusmartinez/portfolio/sbm/.
This methodology defines the sampling set as the voxels that are crossed by the sampling
vector vθ,ϕ. When projecting a structure as complex as the brain, this implies a loss of contextual
information of both the neighbourhood and the layers crossed by vθ,ϕ. Two approaches have been
suggested to overcome this problem: the first one extends the system by dividing the sampling
set Vθ,ϕ in n equal parts in a so-called “Layered approach”, and the second one uses a helical
sampling and Local Binary Patterns (LBP) to map the neighbourhood of the sampling vector and
characterize the texture of the area.
II.3. Layered Extension
The first strategy used to improve the descriptive abilities of the mappings is the Layered Extension.
In this approach, the sampled voxels set Vθ,ϕ can be divided in n equal subsets, using each one to
project one section -or layer- of the brain. If, for example, we use n = 4, 4 subsets containing the
same number of voxels will be derived from Vθ,ϕ, and therefore 4 different maps will be depicted,
from the closest to the centre to the farthest. This layered approach reveals the different anatomical
structures found in the brain at different depths, potentially revealing a more detailed distribution
the features of the mappings . These layered maps and their performance will be discussed later.
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Figure 3: Resulting GM and WM maps of the same control subject using the six proposed measures: Surface, Thickness,
Number of Folds, Average, Entropy and Kurtosis.
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II.4. SBM based on Local Binary Patterns
In a second attempt to overcome the loss of per layer information, we have expanded the influence
of vθ,ϕ to its r-neighbourhood. This has been done by defining a v measure that describes not only
the features of the voxels crossed by vθ,ϕ, but the texture of its neighbourhood using a Volumetric
Radial Volumetric Radial Local Binary Pattern (VRLBP) descriptor.
Local Binary Patterns (LBP) were first introduced in [21] to describe the texture of an image
with application to face recognition. Later, in [22], the technique was extended to a Volume
LBP (VLBP), defining a 3D texture in a local neighbourhood by using a cylinder oriented in one
direction and whose radius define the neighbourhood used to compute the LBP descriptor.
In the VRLBP, the sampling method devised in [22] has been updated to follow helical
coordinates around the mapping vector vθ,ϕ (see helix around vθ,ϕ in Figure 2). Formally, we note








θ,ϕ), . . . I(g
P−1,r
θ,ϕ )} (8)
where the coordinates gp,rθ,ϕ of each voxel are computed in the direction of vθ,ϕ by:
gp,rθ,ϕ =

xp,rθ,ϕ = p sin(ϕ) cos(θ)− r sin(2πn
p
P )
yp,rθ,ϕ = p sin(ϕ) sin(θ) + r cos(2πn
p
P )
zp,rθ,ϕ = p cos(ϕ)
p = {0, ..., P− 1}, P ∈N (9)
being n the number of loops in the helix. Following [22], voxels that do not fall exactly at the
coordinates computed in the equations 9 are estimated by interpolation.
Let us assume, without lost of generality, that P and r are fixed. This way, set of sampled
voxels VP,rθ,ϕ becomes Vθ,ϕ, which matches the definition of Section II.2. Following this notation, the
value v for this VRLBP approach is computed using:
vVRLBP = ∑
i
s(Vθ,ϕ(i)−Vθ,ϕ(0)) · 2i ∀i = 1, . . . P (10)
where s(x) is the sign function, defined as:
s(x) =
{
1 x ≥ 0
0 x < 0
(11)
This approach provides textural information about all brain structures in a certain direction, as it
can be seen in Figure 4.
II.5. Feature Selection
For a further dimensionality reduction, and pixel relevance assessment, we can proceed as in [14],
by selecting the most descriptive voxels according to a criterium. In this case, we will use the
two-sample t-Test with pooled variance estimate. To do so, we define the vector sC that contains
all values v of a certain pixel along all maps belonging to a class C. Hence, a t-value is computed
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Figure 4: An example of the VRLBP projection for GM and WM Tissues.
In our experimental setup, once this t-value has been computed for all pixels in the map, we
rank the pixels from highest to lowest t-value. Finally, a percentage of the most relevant features
is selected as the feature vector that characterizes that image.
III. Results
III.1. Experimental settings and validation
In this work, have considered a binary classification problem: AD vs. NC, where we have evaluate
separately each type of mapping. First, in Section III.2, we will analyse our maps by means of the
t statistic, where the areas of higher statistical significance (AD vs NC) will be highlighted. To
better interpret the results, an anatomical reference is provided.
Second, we have perform a classification analysis using feature selection by means of t-Test,
then training and testing a linear SVM classifier. The method has been validated using stratified
10-fold cross-validation, as recommended in [23]. This procedure consists on randomly partition
the whole datasets into 10 subsets that contains the same proportion of individual of both classes
as the whole database. Then, one subset is used for testing and the remaining 9 are used for
training. This is repeated for each of the subsets as training sets. Finally, the whole cross-validation
strategy will be repeated 10 times to avoid the possible bias and random effects of the partitions,
and obtain the average and standard deviation of the performance values.
Values of accuracy (acc), sensitivity (sens) and specificity (spec) along with their standard
deviation will be employed to evaluate the performance of the different mappings. Selection of
parameter C of the SVM classifier (as implemented in LIBSVM [24]) will be performed using an
inner 5-fold cross-validation on the training subset.
III.2. Statistical Significance Analysis
In this section, we will study the statistical significance of the SBM maps by using a two-sample
t-Test with pooled variance estimate, as defined in Section II.5. The computed t values for
each coordinate pair in the maps (θ, ϕ) will be displayed later in Section III.2.2 for the six
original measures, in Section III.2.3 for the layered extension and in Section III.2.4 for the VRLBP.
However, to provide a better understanding of these t-maps, an anatomical reference is provided
in Section III.2.1.
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III.2.1 Anatomical Reference
Our SBM technique maps all sampled voxels selected by our mapping vector vθ,ϕ to a single point
in the projected map. These points cross different anatomical regions, however it is difficult to
know at first which regions are crossed, given the coordinate pairs (θ, ϕ). To clarify this and
provide a better understanding, we have mapped the widely known Automated Anatomical
Labeling (AAL) [25] map using SBM, and the regions are displayed in Figures 5 and 6.
Figure 5: Projection of different cortical regions. In the Frontal region, we can find: 1) Frontal Sup., 2) Frontal Mid.,
3) Frontal Inf. Oper., 4) Frontal Inf. Tri., 5) Frontal Sup. Orb, 6) Frontal Mid. Orb, 7) Frontal Inf. Orb,
8) Frontal Sup. Medial, 9) Rectus, 10) Frontal Med. Orb., 11) Precentral, 12) Supp. Motor Area. In the
Parietal region: 13) Paracentral Lobe, 14) Postcentral, 15) Parietal Sup., 16) Parietal Inf., 17) Supramarginal,
18) Angular. In the Occipital region: 19) Precuneus, 20) Cuneus, 21) Occipital Sup., 22) Occipital Mid., 23)
Occipital Inf., 24) Lingual. In the Temporal region: 25) Temporal Sup., 26) Temporal Pole Sup., 27) Temporal
Mid., 28) Temporal Pole Mid., 29) Temporal Inf, 30) Fusiform, 31) Parahippocampal. The Cerebellum,
divided in: 32) Cerebelum Crus 1, 33) Cerebelum 3, 34) Cerebelum 4-5, 35) Cerebelum 6, 36) Cerebelum 7b,
37) Cerebelum 8, 38) Cerebelum 9, 39) Cerebelum 10. And additionally, the 40) Medulla, 41) Brain Stem
and 42) Insula.
III.2.2 Spherical Brain Mapping
In this section, the six measures proposed in Section II.2 will be analysed using a t-test. To
proceed, a t-value will be computed for each pixel in the maps, yielding a significance map. These
significance maps, or t-maps, are presented in Figure 7.
Absolute t-values higher than 1.96 can be considered to be significant, with a p < 0.05. In
this case the areas of greater significance are in dark red and dark blue, where red is a positive
t-value, meaning a higher value in controls than in AD subjects, and blue is a negative t-value, and
conversely, blue means negative values, which are related to a higher value in AD than in controls.
The first thing to note is that the distribution of the t values in the Surface mapping, in both
GM and WM, is not relevant at all, with very few significant pixels distributed along the whole
image.
In the remaining GM mappings, greater t-values are located in the frontal, occipital and parietal
lobes, but the most significant areas can be found in the temporal lobe. This is most obvious in the
Average and Entropy mappings, but can also be found in Thickness. Number of Folds and Kurtosis
present high, but however negative, t-values in these areas as well. This suggests that for GM,
most of the neurodegeneration is located in the temporal lobe and all the underlying structures
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Figure 6: Projection of some important subcortical regions and organs. We observe the following subcortical structures:
1) Caudate Nucleus, 2) Olfactory Bulb, 3) Rolandic Operculum, 4) Heschl’s gyri, 5) Putamen, 6) Globus
Pallidus, 7) Amygdala, 8) Hippocampus, 9) Thalamus, 10) Lingual, 11) Vermis 4-5, 12) Vermis 7, 13) Vermis
9, 14) Vermis 1-2, 15) Cingulate Gyrus, 16) Corpus Callosum
Figure 7: t-maps that present the level of statistical relevance in the AD vs. NC paradigm, for each type of mapping
and GM and WM.
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that are projected in this area, including the Hippocampus and Parahippocampal gyrus, which
are considered a fundamental disease indicator in the NINCDS-ADRDA criteria [5]. Additionally,
some structures that are located in the same area have been recently related to the progression
of the disease, such as the Caudate Nucleus and Putamen [4]. These changes are more precisely
located when using one of our spherical maps such as the Average or Entropy.
Conversely, in the WM mappings the selected regions are different. When using Number
of Folds and Thickness, the selected areas are located in the vicinity of those obtained in GM.
However, our spherical maps, especially Average and Entropy, behave differently. There is still
high t-values that correspond to the White Matter of the Parahippocampal gyrus, but large areas of
negative t-values that are located in areas corresponding to the Caudate Nucleus, Globus Pallidus
and Putamen. The areas corresponding to the Posterior Cingulate gyrus and adjacent Precuneus
present also values related to cell loss, as suggested in [2].
III.2.3 Layered Extension
The significance levels of the layered mappings has been assessed as well. However, due to space
restrictions, we will only analyse the anatomical features of one of the mappings: a four-layered
average mapping of the GM, that can be checked in Figure 8.
It is plain to see that most of the neurological changes in GM appear in layers 2 and 3,
specifically in the Hippocampus, Parahippocampal lobe and Amygdala (layer 2) and the temporal
lobe (layer 3), where the values of the average mapping (equivalent to the density of the tissue)
are higher in normal control subjects than in AD affected patients. This reveals atrophy in these
organs, as it has been previously reported in the bibliography [5, 4]. In the case of WM, however,
the changes are negative in the areas where the Rolandic Operculum, Heschl’s gyri, Putamen
and Globus Pallidus are found, and positive in some sections of the Hippocampus and the White
Matter contained in the Parahippocampal lobe and the remaining parts of temporal lobe (layer 2
and 3). Nevertheless, the most significant differences are located in layer 1, in the borders between
ventricles and Thalamus, and specially in the Cuneus, Precuneus and Posterior Cingulate gyrus,
which were reported in [2].
III.2.4 VRLBP
Finally, to end this statistical significance analysis, the t-maps of the more complex VRLBP
mapping are presented in Figure 9.
These maps present low absolute t levels in most of the projection, however some small regions
present high significance. These regions correspond to small areas in temporal lobe, Amygdala
and Hippocampus in the GM, and even smaller regions in the WM corresponding to the limits
between Hippocampus and Amygdala.
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Figure 8: t-maps that present the level of statistical relevance in the AD vs. NC paradigm, for a four-layered average
mapping over a) GM and b) WM.
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Figure 9: t-maps that present the level of statistical relevance in the AD vs. NC paradigm, for the VRLBP projections
mapping over a) GM and b) WM.
III.3. Classification Analysis
To obtain comparable performance metrics suitable to analyse the generalization capabilities of
SBM, in this section a number of classification results are presented. A baseline is established in
Section III.3.1 and then the performance of our maps, included the layered extension and VRLBP,
is presented in Section III.3.2.
III.3.1 Baseline - VAF
In order to establish a baseline to assess the predictive ability of our maps, we will use the
Voxels as Features (VAF) paradigm, described in [6]. This approach uses the whole 3D GM or
WM segmented MR images and then uses all voxels of the 3D images as features in the SVM
classification, yielding the performance values shown in Table 1. The performance of the SBM
maps will be compared to these.
Approach Accuracy Sensitivity Specificity
Vaf (GM) 0.768± 0.011 0.752± 0.016 0.785± 0.016
Vaf (WM) 0.642± 0.009 0.668± 0.012 0.617± 0.013
Table 1: Performance values (Average ± Standard Deviation) for the Voxels as Features approach in both GM and
WM tissues.
III.3.2 Spherical Brain Mapping
In this analysis, we have proceed as commented before, by computing the significance of each
pixel using a t-test and then selecting a proportion of the most relevant, once they have been
ranked according to their t-value. Later, these features are used to train and test a linear SVM
classifier.
The results for each type of map are presented in Table 2, including the percentage of selected
voxels (perc.) at which each value is obtained. Regarding the Grey Matter, we can observe that
the best type of mappings in the diagnosis task, in terms of average accuracy, are the Average
(0.879± 0.005) and Entropy (0.846± 0.008). There results are followed by the measures of Thickness
(0.781± 0.007), Kurtosis (0.753± 0.019) and the worse accuracy estimates are for Number of Folds
(0.749± 0.013) and Surface (0.638± 0.006).
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Approach Perc. Accuracy Sensitivity Specificity
Surface (GM) 0.100 0.638± 0.006 0.660± 0.030 0.616± 0.024
Surface (WM) 0.100 0.672± 0.007 0.692± 0.018 0.652± 0.018
Thickness (GM) 0.725 0.781± 0.007 0.811± 0.011 0.751± 0.017
Thickness (WM) 0.925 0.758± 0.009 0.773± 0.017 0.744± 0.011
Num.Fold (GM) 0.600 0.749± 0.013 0.782± 0.019 0.716± 0.013
Num.Fold (WM) 0.500 0.757± 0.005 0.745± 0.006 0.768± 0.009
Average (GM) 0.575 0.879± 0.005 0.897± 0.006 0.861± 0.006
Average (WM) 0.150 0.800± 0.011 0.802± 0.013 0.798± 0.009
Entropy (GM) 0.825 0.846± 0.008 0.842± 0.009 0.849± 0.011
Entropy (WM) 0.525 0.796± 0.006 0.811± 0.009 0.781± 0.009
Kurtosis (GM) 1.000 0.753± 0.007 0.801± 0.011 0.704± 0.015
Kurtosis (WM) 0.175 0.697± 0.008 0.702± 0.018 0.693± 0.009
VRLBP (GM) 0.200 0.903± 0.010 0.890± 0.012 0.916± 0.018
VRLBP (WM) 0.150 0.909± 0.014 0.899± 0.028 0.919± 0.018
Table 2: Performance values (Average ± Standard Deviation) for the different SBM approaches.
In the case of White Matter, and according to Table 2, the performance is again higher in
Average (0.800± 0.011) and Entropy (0.796± 0.006). Thickness and Number of Folds present
similar, but lower, perfomance values, respectively 0.758± 0.009 and0.757± 0.005, and being the
Kurtosis (0.697± 0.008) and Surface (0.672± 0.007) maps the less powerful.
However, VRLBP outperform all these approaches by obtaining an accuracy of 0.903± 0.010
for GM and 0.909± 0.014 for WM, revealing itself as the best technique.
The evolution of the performance of the maps as the number of selected pixels varies is
shown in Figure 10. In general, it is possible to see very small differences in the accuracy of the
system, which makes its performance almost independent from the number of selected pixels.
However, this is not the case of the Surface, and, more remarkable, the VRLBP. In the latter,
the performance is the best for both tissues when the proportion of selected pixels is small, but
degrades significantly as its number increases.
Regarding the four-layer extension to SBM, the performance values obtained by different
mappings at different layers and thresholds (t-values of 2, 4, 8 and 10) is presented in Figure 11.
The first thing that we can observe is that for both GM and WM tissues, the better performance
is achieved with the second layer. This is specially surprising in the WM case, as the highest
t-values were located in layer 1.
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Figure 10: Performance for the different SBM approaches over the: a) Grey Matter and b) White Matter.
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Figure 11: Performance for the different four-layered mappings over the: a) Grey Matter and b) White Matter at
different levels of statistical significance.
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IV. Discussion
The structural changes in MR images during the progression of the Alzheimer’s Disease are
widely documented in the bibliography [3, 2, 4, 6, 9, 10]. According to our current knowledge, the
neurodegeneration and posterior atrophy occurs mainly in the GM tissue, although significant
changes are present also in WM.
The mappings defined throughout Sections II.2, II.3 and II.4 account for different properties of
the tissues crossed by vθ,ϕ. As it can be seen in Figure 12, our mappings show in general a higher
performance when using the GM tissue, which is consistent with the literature. There are some
exceptions, however, being the clearest the VRLBP, and, to a lesser extent, the number of folds and
surface. The different mappings and their utility will be described in the following paragraphs.
Figure 12: Performance at the operation point for the different mappings over the Grey Matter and White Matter,
compared with the performance of VAF.
The first three approaches, Surface, Thickness and Number of Folds are easily interpreted, as
they intend to represent the surface of the tissue by mapping the distance between the centre of
the image and the last voxel, the thickness of the tissue, and a measure of the complexity of the
different sulci and gyri.
Surface and Thickness are highly related to other measures provided by widely-used software.
However, as they are related to our more general SBM description, their performance is poor,
specially in the case of the Surface mapping. As it can be seen in Fig. 3, and later in the t-maps at
Fig. 7, the detail of the surface map lacks higher detail, specially due to the superposing gyri and
sulci. These superposition occur to a lesser extent in WM tissue, and this is probably why this
technique obtains higher performance in WM than in GM.
As for the case of Thickness, although similar, it gathers much more information than the
surface, without achieving, however, the level of detail of the cortical thickness measures provided
by Freesurfer [10] or other software. Nevertheless, cortical thickness it is a descriptive, widely
accepted as a measure of neurodegeneration in Alzheimer’s Disease in the literature [9, 10], and
its measures might be relevant for a subsequent analysis.
Number of Folds, however, is intended to model the complexity of the cerebral cortex, and
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therefore, it is of far more use in the case of GM than in the WM. This can be easily checked when
looking at the maps obtained for both GM and WM in Figure 3.
The last three measures described in Section II.2 are statistical values that describe the variability
of the sampling set Vθ,ϕ. It would be reasonable to expect the better performance to be linked to
the mapping that better models the tissue atrophy.
This is the case of the average of these intensities, which can be interpreted as the total amount
of tissue, being therefore a good measure of the level of brain atrophy in each direction (θ, ϕ).
The average maps show the best performance of all the measures proposed in Section II.2, and is
higher in GM than in WM. This is consistent with the literature, as atrophy mainly occurs in GM
tissues.
Entropy is a more complex statistical concept that comes from information theory, but is
usually related to the amount of information, or in other words, the “randomness” of a source. In
our particular case it could be interpreted as a measure of texture, that is, the grey-level variability
in the direction of vθ,ϕ. These maps perform very similar to the average ones in both GM and
WM, suggesting that the entropy accounts for the tissue density as well.
The last mapping defined, Kurtosis, is a fourth-order statistic, often interpreted as the peaked-
ness (width of peak) of a probability distribution. In our context, it is related to the sharpness of
the changes in the direction of vθ,ϕ, and thus is related to the number of folds. As in the case of the
latter, the Kurtosis performs poorly in both types of tissues, probably because they are measures
that are not as directly related to atrophy as other measures such as average, entropy or thickness.
The last of the single measures proposed in this work is the Volumetric Radial LBP defined
in Section II.4. It is a measure of the texture not only in the direction of vθ,ϕ, but also in
the neighbourhood of the mapping vector. Therefore, it is not strange that it obtains the best
performance of the whole work, yielding accuracy results above 0.9 for both GM and WM tissues.
This could seem counter-intuitive, as the t-maps for this technique, presented in Fig. 9, show
small regions of high significance, when compared to the measures in Sec. II.2. Yet, despite its size,
it performs fairly well with a relatively small amount of data. It is probably due to the nature of
VRLBP, and the areas highlighted in Fig. 9 probably correspond to the texture changes associated
to the loss of tissue in the Hippocampus.
As for the layered extension, which might seem a powerful method to add detail to the
mappings, obtains however similar performance to the methodology above. It seems that the
amount of information that can be obtained by each measure does not depend on the number of
layers, and accordingly, its benefits are only related to visualization. In this case, best values are
obtained in layer 2, which is consistent to the presence of some organs, specially the Hippocampus.
Finally, in order to have another look at the performance of our mappings, the ROC curves of
each type are presented in Figure 13. There we can see how the VRLBP approach outperforms
all the other measures, specially in the case of WM tissue. In GM, Average and Entropy present
values really close to VRLBP, as expected. Conversely, the poorest performance is achieved by the
Kurtosis and Surface mappings, however the Surface performs better in WM than in GM. These
results confirm the performance values presented in Table 2 and Figure 10, making our proposed
mapping framework a reasonable choice for obtaining both a visual interpretation of otherwise
hidden features and a significant dimensionality reduction.
It is important to note that our Spherical Brain Mapping defines a whole framework that can
be easily extended with different sampling strategies. This is the case of the layered extension
and the helical sampling in VRLBP, but they are only two examples of what can be done. Since
our simplest approach implies a computation of a value from a vector of intensities, measures
used to describe time-course data could be added to complete and highlight different properties
of the tissues. In this context, high-order statistics [26], as well as spectral measures [27] have
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Figure 13: ROC curves of the different mappings for the GM and WM tissues.
been successfully applied to analyse electroencephalogram (EEG) signals, and could be therefore
applied here to bring different structural properties of the images into focus. Additionally, our
mapping method is potentially applicable to other imaging modalities, such as PET and SPECT,
where the structural information is sometimes lost [12, 17]. Our technique does not need the use
of complex co-registering of MRI and functional imaging to locate cerebral structures, as it rely
only in their angle and depth. Moreover, in the case of Diffusion Tensor Imaging (DTI), which
has proven itself as a good tool for the diagnosis of Alzheimer’s Disease [28, 29], SBM could be
modified to replace v`,’ with each tract, and subsequently project a given feature, resulting in a
summary of the tract’s behaviour in a single two-dimensional image.
V. Conclusions
In this work the Spherical Brain Mapping (SBM), a new framework for feature reduction, visual-
ization and analysis of Magnetic Resonance Imaging (MRI) is presented. It is based on a mapping
from 3D spherical coordinates to a 2D map that contains different structural and statistical mea-
sures. Some of the measures are highly related to typical changes in the brain (atrophy, decrement
in cortical thickness), that have been already successfully tested in the diagnosis task.
This new strategy allows both a visual interpretation of different brain features using two-
dimensional maps and a subsequent computational processing that could be used to obtain
objective measures to help physicians in the diagnosis task. Different SBM measures have been
tested in combination with t-value maps (used to select the most relevant pixels in the maps) in
an automatic classification procedure using Alzheimer’s Disease affected patients (AD) versus
Normal Controls (NC). In this case, some of the maps yielded high performance values, matching
and even outperforming well-established methodologies in the field, but with the addition of
a significant computational load reduction. Furthermore, with the addition of a four-layered
mapping, in which different structures of the brain are displayed at different depths, the system
kept these good performance values, while providing a better visual interpretation of the results.
However, the first approach described in this paper is the simplest one that could be stated
-only a feature selection step has been added in the evaluation of the mappings-, with the only
addition of the layered approach. In future works, the SBM framework could be expanded by
adding different types of measures to the set, and the processing pipeline can be improved by
processing the different maps using univariate or multivariate algorithms to make the most of the
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information contained within.
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